Mitchell Worley, MD
Otolaryngology · Spartanburg, SCNPI 1528447281
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,378 of the $3,863 with a category attached, or 61.5%. 24 manufacturers reported payments, led by Aerin Medical Inc. at 59.8% of the total. Reporting peaked in 2024 at $1,993 and has fallen 61.6% since, to $766 in 2025.
Across 88 payments — averaging $43.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- GSK$408
- Integra Lifesciences Corporation$190
- Acclarent, Inc$134
- Stryker$105
- Regeneron Healthcare Solutions, Inc.$85
- plus $632 from 18 others
Across 4 payments — averaging $2188.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$9K
What the payments were for
- Consulting fees$40010%
- Travel & lodging$1,05827%
- Food & beverage$2,37862%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 20 | $2,310 |
| GSK | 28 | $408 |
| Integra Lifesciences Corporation | 2 | $190 |
| Acclarent, Inc | 4 | $134 |
| Stryker | 4 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| AstraZeneca | 1 | $84 |
| Cochlear Americas | 2 | $76 |
| Inari Medical, Inc. | 1 | $56 |
| Alk-abello, Inc | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Medtronic(2 entities) | 2 | $46 |
| Amgen | 2 | $37 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $30 |
| Resmed Corp | 2 | $28 |
| 3nt Medical | 1 | $27 |
| Baxter Healthcare | 1 | $27 |
| Genentech USA, Inc. | 1 | $27 |
| Smith+Nephew | 1 | $26 |
| Merck | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Sanofi | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,181
- Acclarent Aera$175
- Inspira Air$175
- RELIEVA SPINPLUS NAV$175
- TruDi Probe$175
- NUCALA$125
How this compares
$3,863 in reported general payments places this provider in the 80th percentile of 180 otolaryngology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 218 | $6,838 |
| Azelastine Hcl | 234 | $5,323 |
| Epinephrine | 16 | $3,337 |
| Fluocinolone Acetonide Oil | 54 | $1,919 |
| Fluticasone Propionate | 149 | $1,689 |
| Ofloxacin | 109 | $1,159 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 84 | $740 |
| Doxycycline Monohydrate | 68 | $660 |
| Omeprazole | 43 | $588 |
| Dexamethasone Sodium Phosphate | 13 | $574 |
| Famotidine | 35 | $545 |
| Mupirocin | 80 | $471 |
| Montelukast Sodium | 29 | $418 |
| Cefdinir | 11 | $177 |
| Fluconazole | 20 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $15 | $3,33716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 180 otolaryngology providers in South Carolina.
Other otolaryngology in Spartanburg
- John FosterSpartanburg$4K
- David WeirSpartanburg$3K
- Shaun NguyenCharleston$973K
- Rodney SchlosserCharleston$382K
- Zachary SolerCharleston$67K
- Peter HorwichNorth Charleston$33K
- Eugene BrownCharleston$28K
- Jason NewmanCharleston$26K
- Joshua HornigCharleston$25K
- Ashli OrourkeCharleston$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.